1 Min Read
Oct 26 (Reuters) - HEIDELBERG PHARMA AG:
* DGAP-NEWS: HEIDELBERG PHARMA AG: PARTNER REDHILL ANNOUNCES ORPHAN DRUG DESIGNATION FOR MESUPRON Source text for Eikon: Further company coverage: (Gdynia Newsroom)
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2018 Reuters. All Rights Reserved.